SCHEMBL17909262

SCHEMBL17909262

CCOCCOCCOCCCC(=O)OCC(C)C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.45
▸ TSHR P16473 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ DGKA P23743 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ EPHX2 P34913 2/20 0.39
▸ PRKCA P17252 1/20 0.37
▸ PRKCE Q02156 1/20 0.37
▸ PRKCQ Q04759 1/20 0.37
▸ PRKCD Q05655 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17909203 1.00 MAPT (0.45) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL17909353 1.00 MAPT (0.45) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL20210473 0.96 MAPT (0.47) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL20210695 0.91 MAPT (0.50) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL17908948 0.90 MAPT (0.38) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL17909480 0.90 MAPT (0.53) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL17908768 0.90 MAPT (0.53) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL20210596 0.90 MAPT (0.53) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL17909291 0.90 MAPT (0.53) MAPTTSHRALDH1A1LMNACYP3A4
SCHEMBL17909674 0.89 MAPT (0.43) MAPTTSHRALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048093-B1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORP (JP) 2019-02-20 — — EP disclosed
US-10077229-B2 Ether-containing monoester compound and use thereof MORESCO CORPORATION (JP) 2018-09-18 — — US disclosed
EP-3048093-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF Moresco Corporation (JP) 2016-07-27 — — EP disclosed
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORPORATION (JP) 2016-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077229-B2 Ether-containing monoester compound and use thereof SFN, CCNE2, HSD3B2 MAPT 3437/4885TSHR 4877/4885ALDH1A1 1635/4885
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF SFN, CCNE2, MSMO1 MAPT 3717/4885TSHR 4877/4885ALDH1A1 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback